Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Patients With Advanced Hematologic Malignancies

NCT00642031 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Hematologic Malignancies
Leukemia

Interventions

DRUG: Triciribine

Sponsor

Prescient Therapeutics, Ltd.

Collaborators

[object Object]